MedTrace Logo

Efficacy of Universal Bonding Agents as Desensitizers

NCT07197437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-09-29

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the adhesive Single Bond Universal works to treat dentin hypersensitivity in adults. It will also learn about the durability of Single Bond Universal. The main questions it aims to answer are:

Does Single Bond Universal has the function to treat dentin hypersensitivity in adults? Researchers will compare Single Bond Universal to a traditional desensitizer Hybrid Coat to see which one has higher efficiency and longer durability.

Participants will:

Receive the treatment of Single Bond Universal or Hybrid Coat at the first visit.

Visit the clinic at 1, 3, 6, 9, 12 months for follow-up evaluation. Reassess dentin sensitivity at each visit and record in terms of VAS score.

Conditions

  • Dentin Hypersensitivity

Interventions

DEVICE

Hybrid Coat desensitizer

Dental desensitization treatment

DEVICE

Single Bond Universal as desensitizer

Dental desensitization treatment

Sponsors & Collaborators

  • Peking University Hospital of Stomatology

    lead OTHER

Principal Investigators

  • Xue Cai · Peking University School and Hospital of Stomatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-27
Primary Completion
2025-03-07
Completion
2025-03-07

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07197437 on ClinicalTrials.gov